Increase in Share Capital and Listing of New B-shares resulting from Euroclone Acquisition
22.05.2013 09:00
Biohit to strengthen its GastroPanel distribution in China - new partner Hefei Medicine
16.05.2013 15:00
Biohit Oyj Interim report Q1-2013
25.04.2013 09:30
GastroPanel Seminar
Almaty, Kazakhstan
AACC American Association for Clinical Chemistry
Houston, Texas, USA
Biohit HealthCare's unique GastroPanel examinations diagnose diseases of the stomach
and the risks associated with these diseases. Our quick tests provide diagnosis
of lactose intolerance and Helicobacter
pylori infection, as well as fecal occult blood, a well-known marker for
colorectal cancer. Instruments for analysing the test results are also available in our product range.
The new over-the-counter products eliminate carcinogenic acetaldehyde thus reducing the risk of cancers of the gastrointestinal tract.
Biohit Oyj sold its liquid handling segment to Sartorius Lab Holding GmbH in December 2011. Read more about Sartorius Biohit Liquid Handling Oy.
Biohit is a main sponsor of Healthy Stomach Initiative,
read more: www.hsinitiative.org